An abuse-deterrent pharmaceutical composition has been developed to reduce the likelihood of improper administration of drugs, especially drugs such as opiods. In the preferred embodiment, the drug is modified to increase its lipophilicity by forming a salt between the drug and one or more fatty acids...http://www.google.fr/patents/US20050281748?utm_source=gb-gplus-shareBrevet US20050281748 - Abuse-deterrent drug formulations
Numéro de demande: 11/149,867 Numéro de publication: US 2005/0281748 A1 Date de dépôt: 10 juin 2005 Brevet délivré: US7771707 ( Date de délivrance 10 août 2010)
